An in-depth analysis of high-purity Orlistat API manufacturing, chemical purity standards, global regulatory compliance, and supply chain resilience.
Orlistat, chemically known as (S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate (CAS 96829-58-2), remains one of the most clinically established and commercially successful non-systemic pancreatic lipase inhibitors worldwide. Unlike centrally acting weight loss agents, Orlistat exerts its therapeutic efficacy locally within the lumen of the stomach and small intestine by covalently binding to the active serine site of gastric and pancreatic lipases.
As the global pharmaceutical sector demands heightened purity profiles, minimizing solvent residues, diastereomeric impurities, and degradation byproducts (such as Impurity A, B, C, and D) has become paramount for generic formulation developers and brand owners alike. Partnering with a specialized China Purity Orlistat Supplier & Factory capable of delivering cGMP-compliant batches with assay levels exceeding 99.0% (and optimized up to 99.5%+) offers pharmaceutical brand managers a critical competitive advantage.
Gentolex Group stands at the forefront of this chemical synthesis evolution, providing global buyers with fully validated analytical dossiers, DMF support, and batch-to-batch stability metrics.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our primary services focus on supplying synthetic peptide APIs, custom peptides, high-purity small molecule active pharmaceutical ingredients, FDF (Finished Dosage Form) licensing out, technical support & consultation, product line and laboratory setup, alongside tailored sourcing and supply chain solutions.
An overall factory construction area of 250,000 square meters operating under international cGMP standards to offer flexible, scalable, and cost-effective batch manufacturing from lab-scale R&D to multi-ton commercial orders.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Complete regulatory documentation and certificates (CoA, MoA, DMF, CEP support) are supplied to customers worldwide.
Full-cycle synthetic optimization, custom peptide sequence synthesis, chiral resolution, and stability testing ensuring seamless scale-up and process safety evaluation for clinical pipeline candidates.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Comparing standard commercial Orlistat specifications with Gentolex High-Purity Premium Grade (EP / USP Aligned)
| Test Parameter | USP / EP Standard Requirement | Gentolex High-Purity Orlistat Specification | Analytical Methodology |
|---|---|---|---|
| Appearance | White to off-white powder | White crystalline powder / granular | Visual Inspection |
| Identification (IR / HPLC) | Conforms to reference standard | Conforms strictly to USP/EP Reference | FTIR & HPLC Retention Time Alignment |
| Assay (Drying Basis) | 98.0% - 101.5% | 99.2% - 100.5% (High Assay) | RP-HPLC with UV Detection |
| Enantiomeric / Chiral Purity | Not explicitly defined (Specified) | ≥ 99.8% (Single Isomer) | Chiral HPLC Column Analysis |
| Related Substances (Individual) | Impurity A ≤ 0.2%, Impurity B ≤ 0.15% | Individual Impurity < 0.08% | High Sensitivity RP-HPLC |
| Total Impurities | ≤ 1.0% | ≤ 0.3% | Mass Balance RP-HPLC |
| Residual Solvents | Meets ICH Q3C Limits | Solvents significantly below ICH limits (Headspace) | Headspace GC-FID / GC-MS |
| Heavy Metals / Elemental Impurities | Meets ICH Q3D Limits | Total Heavy Metals < 5 ppm | ICP-MS Method |
| Bacterial Endotoxins | Specified per application requirement | < 0.1 EU/mg (Ultra-clean grade available) | LAL Kinetic Chromogenic Test |
Navigating the global shift in metabolic therapeutics, oral non-systemic weight management solutions, and OEM formulation demands.
While injectable GLP-1 receptor agonists (e.g., Semaglutide, Tirzepatide) dominate headline prescription markets, Orlistat continues to command massive global market share in the Over-The-Counter (OTC) and affordable prescription sectors due to its oral convenience, safety profile, and lack of systemic absorption risks.
Global pharmaceutical firms in Latin America (Mexico hub), Africa (South Africa hub), South East Asia, and Europe are seeking direct, verified manufacturing relationships with Chinese factories to hedge against intermediary price markups and guarantee reliable batch continuity.
Modern fast-dissolving capsule and chewable tablet formulations require optimized API particle size distribution (PSD). Micronized Orlistat (D90 < 20μm or customized mesh size) enhances dispersion and consistent lipid binding inside the gastrointestinal tract.
Comprehensive solutions tailored for pharmaceutical brand owners, distributors, and contract manufacturers.
We supply high-purity Orlistat API in commercial packaging (1kg, 5kg, 25kg fiber drums with double PE liners) under controlled thermal monitoring. Every shipment is backed by batch CoAs, stability data under zone IVb conditions, and full DMF documentation.
For brand owners expanding their OTC or Rx weight management portfolio without expanding internal production infrastructure, Gentolex offers FDF licensing options. Formulations available include:
Gentolex delivers strategic engineering support for local manufacturers setting up active peptide and API processing lines, cleanroom environments, analytical testing facilities, and validation protocols.
Eliminate multi-vendor friction through integrated supply orchestration. We facilitate audit support, registration submission files (CTD format), and direct regional account management across key overseas territories.
Ensuring frictionless importing, regulatory authorization, and rapid logisitical execution across global markets.
With direct representative operations in Mexico, Gentolex streamlines LATAM regulatory filings (COFEPRIS compliance), customs clearings, and localized technical consultations, mitigating cross-border communication delays.
Established regional presence in South Africa enables seamless interaction with SAHPRA regulatory guidelines, offering local procurement teams flexible payment setups and accelerated shipping routes.
Facilities undergo rigorous self-inspections and third-party customer audits. Comprehensive documentation packets (CTD Module 3, GMP Certificates, Stability Reports) ensure zero regulatory bottlenecks during national drug registrations.
How Gentolex is shaping the future of lipophilic enzyme inhibitor manufacturing.
Transitioning traditional multi-step chemical reactions to bio-catalytic enzymatic pathways, reducing organic solvent usage by over 40% and lowering impurity profiles.
Implementation of advanced air-jet micronization and online laser diffraction analysis to supply custom PSD tailored specifically for direct capsule filling.
Developing micro-encapsulated pelleted technologies that minimize gastrointestinal discomfort while preserving local lipase binding kinetics.
Integrating end-to-end batch tracking with verifiable analytical certificates, allowing procurement managers real-time visibility into compliance status.
Explore recent technical breakthroughs, peptide synthesis developments, and API market reports from our expert R&D team.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Originally developed through neuropharmacological research, Selank represents a key advancement in neuroactive peptides...
Read Article →
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and commercial drug developers worldwide...
Read Article →
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, and cellular signaling modulation...
Read Article →
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax API features rigorous optical purity and low bioburden...
Read Article →
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting bioenergetic stability...
Read Article →Essential answers regarding Orlistat API procurement, quality validation, storage, and regulatory filings.
Our commitment to rigorous cGMP quality management systems is recognized across global regulatory bodies and audit networks.
